OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors
Liangliang Xu, Chang Zou, Shanshan Zhang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy
Letong Cai, Yuchen Li, Jiaxiong Tan, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 129

Recent advances in targeted strategies for triple-negative breast cancer
Shuangli Zhu, Yuze Wu, Bin Song, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 113

Spatial transcriptomics: Technologies, applications and experimental considerations
Ye Wang, Bin Liu, Gexin Zhao, et al.
Genomics (2023) Vol. 115, Iss. 5, pp. 110671-110671
Open Access | Times Cited: 80

Nanozyme-mediated biocatalysis as a mitochondrial oxidative stress amplifier for tumor nanocatalytic immunotherapy
Junya Lu, Luming Song, Shuaipeng Feng, et al.
Chemical Engineering Journal (2023) Vol. 481, pp. 148270-148270
Closed Access | Times Cited: 79

Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment
Zhifei Gao, Yifeng Bai, Anqi Lin, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 73

Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy
Mengke Niu, Ming Yi, Yuze Wu, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 50

cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment
Hongying Zhang, Yongliang Liu, Jieya Liu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 37

Targeting TIGIT for cancer immunotherapy: recent advances and future directions
Peng Zhang, Xinyuan Liu, Zhuoyu Gu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 32

Versatile function of NF-ĸB in inflammation and cancer
Qiang Ma, Shuai Hao, Weilong Hong, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 24

Anti-TGF-β/PD-L1 bispecific antibody synergizes with radiotherapy to enhance antitumor immunity and mitigate radiation-induced pulmonary fibrosis
Yuze Wu, Yuheng Yan, Yarong Guo, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 2

Dressing Bacteria With a Hybrid Immunoactive Nanosurface to Elicit Dual Anticancer and Antiviral Immunity
Ying Liu, Mengmeng Zhang, Xinyue Wang, et al.
Advanced Materials (2022) Vol. 35, Iss. 11
Closed Access | Times Cited: 57

High tumor mutational burden predicts favorable response to anti-PD-(L)1 therapy in patients with solid tumor: a real-world pan-tumor analysis
Sun-Young Jung, You Jeong Heo, Sehhoon Park
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 4, pp. e006454-e006454
Open Access | Times Cited: 42

A Noninvasive Approach to Evaluate Tumor Immune Microenvironment and Predict Outcomes in Hepatocellular Carcinoma
Jianmin Wu, Wanmin Liu, Xinyao Qiu, et al.
Phenomics (2023) Vol. 3, Iss. 6, pp. 549-564
Open Access | Times Cited: 31

Detection of diagnostic and prognostic methylation-based signatures in liquid biopsy specimens from patients with meningiomas
Grayson Herrgott, James M. Snyder, Ruicong She, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27

Manipulating the tumor immune microenvironment to improve cancer immunotherapy: IGF1R, a promising target
Marsha Pellegrino, Valerio Secli, Silvia D’Amico, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12

Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model
Kun Zheng, Youlong Hai, Hongqi Chen, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9

Biomechanics in the tumor microenvironment: from biological functions to potential clinical applications
Hao Peng, Zheng Chao, Zefeng Wang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 1

Reshaping the immune microenvironment and reversing immunosenescence by natural products: prospects for immunotherapy in gastric cancer
Zhipeng Cao, Zhilin Wang, Yang Li, et al.
Seminars in Cancer Biology (2025) Vol. 110, pp. 1-16
Closed Access | Times Cited: 1

Novel immune checkpoint targets: A promising therapy for cancer treatments
Mohsina Patwekar, Nouroz Sehar, Faheem Patwekar, et al.
International Immunopharmacology (2023) Vol. 126, pp. 111186-111186
Closed Access | Times Cited: 22

Chemodynamic/Photothermal Synergistic Cancer Immunotherapy Based on Yeast Microcapsule-Derived Au/Pt Nanoparticles
Runzan Zhang, Xianya Qin, Junyu Lu, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 20, pp. 24134-24148
Closed Access | Times Cited: 20

Immunotherapy: cancer immunotherapy and its combination with nanomaterials and other therapies
Yuanyuan Guo, Fengyuan Gao, Adeel Ahmed, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 36, pp. 8586-8604
Closed Access | Times Cited: 19

TME-targeted approaches of brain metastases and its clinical therapeutic evidence
Ibrar Muhammad Khan, Safir Ullah Khan, Hari Siva Sai Sala, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18

Targeted delivery of nano-radiosensitizers for tumor radiotherapy
Shuzhi Shi, Haibo Zhong, Yong Zhang, et al.
Coordination Chemistry Reviews (2024) Vol. 518, pp. 216101-216101
Closed Access | Times Cited: 8

Unraveling the complexities of colorectal cancer and its promising therapies – An updated review
Sayan Saha, Shreya Ghosh, Suman Ghosh, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113325-113325
Closed Access | Times Cited: 7

Page 1 - Next Page

Scroll to top